Growing Prevalence of Pcos and Obesity to Support the Growth of Women’s Health Care Market

Women's Health Care Market

The Womens HealthCare Market growth is primarily driven by factors such as the growing incidence of chronic health conditions among women, government initiatives to curb population growth, and growing demand for contraceptives to prevent unintended pregnancies. Moreover, the growing focus on R&D by key players for …

Contract Research Organization (CROs) Services Market worth $86.5 billion by 2026 – Exclusive Report by MarketsandMarkets™

Contract Research Organization (CROs) Services Market

The Contract Research Organization (CROs) Services Market is estimated to grow from USD 115.1 billion by 2027 from USD 68.3 billion in 2022, at a CAGR of 11.0 % during the forecast period. Increasing investment in pharmaceutical R&D:Most pharmaceutical, biopharmaceutical, and medical device companies continue to invest heavily in …

Clinical Trial Supplies Market – Future Revenue Growth Driving Factors

Major Objectives Behind This Study: # To define, describe, and forecast the global clinical trial supplies market based on type, therapeutic area, service, end user, phase, and region. # To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, and opportunities). # To forecast the size of the market segments with respect to four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. # To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market. # To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders. # To profile key market players and comprehensively analyze their service portfolios, market positions, and core competencies. # To track and analyze competitive developments such as acquisitions, service launches, expansions, partnerships, collaborations in the market. Recent Developments: # In April 2021, Thermo Fisher announced plans to acquire PPD for USD 17.4 billion to enhance its offerings in clinical research services and to support clinical trials. # In April 2021, Parexel collaborated with Veeva Systems to improve their clinical processes for clinical trial delivery and enhance Veeva’s cloud technology. Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059 Major Growth Driving Factors: Market growth is largely driven by the increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the growing number of clinical trials conducted globally. However, the increasing cost of drug development and clinical trials is expected to restrain the growth of this market during the forecast period. RESTRAINTS: High cost of drug development Drug discovery and development involve high costs due to the high attrition rate of drug candidates in development. Since R&D for some rare diseases is very challenging and requires a specific group of people to conduct a clinical trial, drug R&D processes can be prone to failure. Only 7 out of 100 cancer drugs that reach the clinical testing phase end up gaining regulatory approval; most drugs fail long before this point. From drug discovery through FDA approval, developing a new medicine, on average, takes 10–15 years and costs USD 2.6 billion. Less than 12% of candidates that make it to Phase I clinical trials are approved by the FDA. This is a key factor limiting the growth of the market. OPPORTUNITY: R&D investments offer significant opportunities for the market North America and Europe, traditionally the major hubs for clinical trials, are facing challenges in terms of trial costs and patient pools. Recent health reforms in the US, the patent expiry of blockbuster drugs, and the global economic slowdown have affected the profitability of pharmaceutical companies. This is compelling several pharmaceutical companies to look for opportunities in emerging countries across the APAC, such as India, Singapore, South Korea, and China, which offer advantages such as reduced costs and easy access to a large heterogeneous patient population.  Collaborations or expansions between companies in this market indicate that they are moving towards emerging markets to help their clients reduce the overall time consumed in clinical trials, thereby reducing their overall cost and resulting in the earlier launch of products in the market (post regulatory clearance). CROs can exploit these opportunities by supporting pharmaceutical companies to fulfill their needs for clinical trial supplies. End Users: The pharmaceutical and biotechnology companies segment accounted for the largest share in 2020 Based on end users, the clinical trial supplies market is categorized into three segments—pharmaceutical & biotechnology companies, contract research organizations (CROs), and medical device companies. The pharmaceutical and biotechnology companies accounted for the largest share of 70% of this market in 2020. This share is attributed to the rising R&D efforts by these companies. Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=172240059 Geographical Growth Dynamics: North America was the largest regional market for clinical trial supplies in 2020. Geographically, the market is segmented into North America, Europe, Asia Pacific, RoW. In 2020, North America accounted for the largest share of the clinical trial supplies market, followed by Europe & Asia Pacific. The growing number of registered clinical trials and significant investments in R&D for clinical trials in this region are major factors driving the growth of the North American market. The presence of many global pharmaceutical giants, such as Pfizer, Abbott Laboratories, and Johnson & Johnson (which outsource their clinical trials to reduce the costs and time associated with completing these trials) in this region is another key driver for market growth. Projected Surge in Revenue Generation: The global clinical trial supplies market is projected to reach USD 2.9 billion by 2026 from USD 1.9 billion in 2021, at a CAGR of 8.5% during the forecast period of 2021 to 2026.

Animal Parasiticides Market worth $13.7 billion by 2026

Overview of This Study: This study involved four major approaches in estimating the current animal parasiticides market size. Extensive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing …

Who are the key manufacturers in the Immunotherapy Drugs Market?

Immunotherapy Drugs Market

Introduction of the global Immunotherapy Drugs Market: The intangible facts surrounding the key restraints, opportunities, & risks that are anticipated to affect the industry’s development during the forecast period are investigated in the Immunotherapy Drugs Market report (2022-2026). Other assessments, like supply & demand, imports & exports, distribution networks, …

Who are the key manufacturers in the Immunotherapy Drugs Market?

Immunotherapy Drugs Market

Introduction of the global Immunotherapy Drugs Market: The intangible facts surrounding the key restraints, opportunities, & risks that are anticipated to affect the industry’s development during the forecast period are investigated in the Immunotherapy Drugs Market report (2022-2026). Other assessments, like supply & demand, imports & exports, distribution networks, …

Bone & Joint Health Supplements Market Regional Analysis and Forecast by 2027

The Bone & Joint Health Supplements Market is estimated to be valued at USD 11.7 billion in 2022. It is projected to reach USD 17.6 billion by 2027, recording a CAGR of 8.5% during the forecast period. The global bone & joint health supplements market has …

Fill Finish Manufacturing Market – Major Pillars of the Global Industry Growth

Key Questions Addressed by the Report: # Who are the major market players in the fill finish manufacturing market?# What are the regional growth trends and the largest revenue-generating regions in the fill finish manufacturing market?# What are the major drivers and challenges in the fill finish manufacturing …

New Release: Clinical Trials Market Study Report Based on Size, Shares, Opportunities, Industry Trends and Forecast to 2025

clinical-trials-market (1)

Introduction of the global Clinical Trials market: The intangible facts surrounding the key restraints, opportunities, & risks that are anticipated to affect the industry’s development during the forecast period are investigated in the Clinical Trials Market report (2022-2026). Other assessments, like supply & demand, imports & exports, distribution networks, …

Know More About the Global Key Players in the High Potency APIs Market

Overview: This research study involved the extensive use of secondary sources; directories; databases such as D&B, Bloomberg Business, and Factiva; white papers; annual reports; company house documents; and SEC filings of companies. Secondary research was mainly used to identify and collect information useful for the …

Pressure Vessel Market to Witness Revolutionary Growth by 2027

Pressure Vessel Market

According to the new market research report “Pressure Vessel Market by Type (Boiler, Reactor, Separator), Material, Heat Source (Fired Pressure Vessel and Unfired Pressure Vessel), Application (Storage Vessels and Processing Vessels), End-User and Region – Global Forecast to 2027″, published by MarketsandMarkets™, The global pressure …

Pharmaceutical Excipients Market – Emerging Trends & Global Future Forecasts

Research Methodologies Followed for This Study: Primary Research: In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as …

Active Pharmaceutical Ingredient Market – Impact of COVID19 on Global Pharma Manufacturing Market

Global Active Pharmaceutical Ingredient Market Dynamics DRIVER: Adoption of organ on chip models in drug development Despite massive investments in pharma R&D, there has been a direct decrease in the annual number of new FDA-approved drugs—almost directly proportional to the increase in R&D spending. To curb the …

Apac Is The Largest Temperature Controlled Packaging Solutions Market

temperature-controlled-packaging-solutions-market5

Temperature Controlled Packaging Solutions Market by Type (Active, Passive), Product, Usability (Single, Reuse), Revenue type (Product, Service), End-Use Industry (Pharma and Biopharma) & Region – Trends and Forecasts Up to 2026